3 4 rata portion (based on the number of Initial Preferred Shares each Buyer purchased in relation to the total number of Initial Preferred Shares purchased by the Buyers) of the aggregate number of Put Preferred Shares, along with the related...Securities Purchase Agreement • February 25th, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 25th, 1998 Company Industry Jurisdiction
1 EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of January 8, 1998, by and among Oncor, Inc., a Maryland corporation, with headquarters located at 209 Perry Parkway, Gaithersburg, Maryland 20872...Registration Rights Agreement • February 25th, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 25th, 1998 Company Industry Jurisdiction
b) Accuracy of the Subscriber's Representation and Warranties. The representations and warranties of the Subscriber shall 3 - 3 -Subscription Agreement • January 24th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJanuary 24th, 1997 Company Industry Jurisdiction
FOR VALUE RECEIVED, the Company promises to pay to ______________________, having an address at ______________________, the holder hereof, or its order (the "Holder"), the principal sum of ______________________ United States Dollars (U.S. $_______)...Oncor Inc • February 28th, 1997 • In vitro & in vivo diagnostic substances
Company FiledFebruary 28th, 1997 Industry
EXHIBIT A --------- ONCOR, INC. ----------- STOCK OPTION AGREEMENT ---------------------- WITNESSETH: -----------Stock Option Agreement • January 29th, 1996 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledJanuary 29th, 1996 Company Industry Jurisdiction
1 EXHIBIT 10.1 STOCK EXCHANGE AGREEMENT THIS STOCK EXCHANGE AGREEMENT (the "Agreement") is made as of the 24th day of February, 1998, by and among Oncor, Inc., a Maryland corporation ("Oncor"), and the persons listed on Schedule A hereto...Stock Exchange Agreement • September 2nd, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledSeptember 2nd, 1998 Company Industry Jurisdiction
c) Performance by the Subscriber. The Subscriber shall have performed, satisfied and complied in all respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Subscriber at or...Subscription Agreement • February 28th, 1997 • Oncor Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 28th, 1997 Company Industry Jurisdiction
ONCOR, INC. -----------Non-Statutory Stock Option Agreement • January 29th, 1996 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledJanuary 29th, 1996 Company Industry Jurisdiction
AND ONCOR, INC. 200 PERRY PARKWAYOncor Inc • May 15th, 1997 • In vitro & in vivo diagnostic substances
Company FiledMay 15th, 1997 Industry
ONCOR, INC. MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • May 22nd, 1998 • Oncor Inc • In vitro & in vivo diagnostic substances • Maryland
Contract Type FiledMay 22nd, 1998 Company Industry Jurisdiction